View Article

Abstract

Objective: The goal of the current study was to develop and evaluate medicated chewing gum containing caffeine. Method: The chicle gum base was prepared by heating latex from the Sapodilla monikara tree in a water bath. To create a homogeneous mixture, lecithin obtained from eggs was added and heated for 45 minutes at 60°C. Glycerol was added to lessen stickiness after talcum powder was added for structure. For stability, the prepared gum base was kept in amber glass vials. Lecithin was extracted from the egg yolk separately by dissolving it in acetone, homogenizing it for 20 minutes, and then washing it with petroleum ether and chloroform. After filtering, the white precipitate was oven-dried for 30 minutes. After softening the gum base at 60°C, mannitol, coconut oil, and caffeine powder were added. Agents for flavoring and coloring were added once the mixture had cooled below 40°C. After molding and cooling, the gum was packaged. Results: The conventional evaluation criteria were met by all chewing gum formulations containing caffeine, suggesting that their quality was satisfactory. Formulation F1 performed the best out of all of them, meeting every requirement. Its overall performance, stability and uniformity made it the best option for a medicated gum delivery system. Conclusion: Chicle gum base from Sapodilla monikara was combined with caffeine as the active ingredient. The formulation was enhanced by modified egg lecithin, and studies revealed that F1 was the best formulation.

Keywords

Chicle gum base, Egg Lecithin, Sapodilla monikara tree, Homogenizing

Introduction

Medicated chewing gum (MCG) is a new and increasingly investigated medication delivery platform, with several benefits over traditional oral dose forms. By avoiding first-pass metabolism and facilitating systemic drug absorption through the buccal mucosa, MCG, which is intended for mastication rather than ingestion, improves bioavailability and onset of action in addition to facilitating local therapeutic effect in the oral cavity 1. MCG has established itself as a useful dosage form in contemporary pharmaceutical research due to its user-friendly character, advantages such as simplicity of administration, quick therapeutic action, and improved patient compliance, especially among pediatric and geriatric populations. Caffeine (1,3,7-trimethylxanthine), a common central nervous system stimulant, is used to fight fatigue, improve alertness, and enhance cognitive function.There is usually a lag in the therapeutic start of traditional caffeine delivery methods, such as capsules or beverages, because of delayed gastrointestinal absorption. MCG has been suggested as a more effective distribution method to get over this restriction. Caffeine-containing chewing gum assurances quicker drug release and action by promoting buccal absorption, which is especially helpful in high-demand scenarios like emergency medicine and military operations 2. Chicle, a naturally occurring gum base made from    the sap of the Manilkara zapota tree, is significant both ecologically and historically. It is a sustainable and well-liked substitute for synthetic gum bases due to its superior mechanical strength, biocompatibility, and biodegradability. Chicle's inclusion in caffeine MCG improves the chewing experience and gum matrix's structural integrity, in addition to being in line with pharmaceutical methods that are ecologically aware 3. Current studies back up MCG's viability and growing usefulness. The potential of MCG for buccal drug delivery was highlighted by Gururajbhat et al., who reported that their formulations had acceptable mechanical characteristics and drug release behavior 1. The use of MCG for the administration of bronchodilators such as terbutaline sulfate was investigated by Mishra et al., demonstrating its suitability for systemic diseases requiring rapid onset 2. The advantages of employing solid dispersion techniques to enhance solubility and release kinetics in chewing gum systems were also documented by Sharma et al. 4. The potential of vitamin C-loaded MCG as a supplemental medication that combines nutritional and dental health benefits was also shown by Pujari et al.5 The current study intends to develop and assess a medicated chewing gum with caffeine based on chicles in light of these advancements. Its physical properties, drug release behavior, and therapeutic efficacy have to be evaluated, with a focus on the use of sustainable excipients. This study adds to the increasing amount of research on efficient, environmentally friendly, and patient-friendly drug delivery methods.

MATERIALS AND METHODS

Materials: All of the reagents and substances utilized in the investigation were of analytical quality. Natural rubber latex was obtained from the medicinal garden of Rani Chennamma College of Pharmacy. Glycerin and coconut oil were procured from Mehta Sons, Bangalore, while mannitol, soy lecithin, and talc were supplied by Burgoyne Burbidges, Mumbai. Caffeine was sourced from Universal Scientific Works, Bangalore. The instruments used in this study included an electronic balance and an ultrasonicator, both supplied by The Indo Sati Instruments and Chemicals. UV absorbance readings were obtained using a UV spectrophotometer (Shimadzu-1800, Japan).

METHODS

Preparation of Standard Calibration Curve of Caffeine: Using UV spectrophotometry, a standard calibration curve for caffeine was created. In chloroform, caffeine has a maximum absorbance (λmax) at 274 nm in the 200–400 nm wavelength range. Ten milligrams of pure caffeine were precisely weighed and dissolved in one hundred milliliters of chloroform to create a stock solution with a concentration of 100 µg/mL. Standard solutions including concentrations of 2, 4, 6, 8, 10, and 12 µg/mL were made from this sample by appropriately diluting it. At 272 nm, the absorbance of every solution was measured.

Extraction of Egg Lecithin from Egg Yolk

Figure 1: Extraction of Egg Lecithin from Egg Yolk

Procedure: To extract lecithin, the egg yolk was carefully separated from the egg and dissolved in acetone. The mixture was homogenized for 20 minutes to facilitate the extraction process. The precipitate obtained was separated and subjected to a second homogenization step. The precipitate was then repeatedly washed with chloroform until a clear, white color was observed, ensuring the removal of impurities. Subsequently, it was washed with petroleum ether, followed by filtration to remove any residual solvents. To get a stable result, the purified lecithin was lastly dried for 30 minutes in a hot air oven, as in Figure 1. This method ensures the efficient extraction and purification of high-quality egg lecithin.7

Preparation of Chicle Gum Base from Sapodilla monikara

The chicle gum base was formulated using latex extracted from Sapodilla monikara, sourced from the medicinal garden of Rani Chennamma College of Pharmacy. Latex collection was performed by making a clean incision at the tip of the plant, with the exudate immediately transferred into a sterile container. The latex was then placed in a clean, dry metal vessel and gently heated in a water bath. Upon softening of the gum base, freshly extracted egg yolk lecithin (prepared in a prior step) was introduced as an emulsifying agent. The temperature was carefully maintained at 60?°C for 45 minutes to facilitate uniform dispersion of lecithin within the latex. Glycerol was incorporated into the molten mixture to reduce the inherent stickiness of the formulation and enhance its processability. Subsequently, talcum powder was added as a structural filler to improve the physical integrity of the gum. The final gum base was stored in amber-colored glass containers to protect it from light-induced degradation and preserve its stability.8

Characterization of Isolated gum base:

  1. Color: A visual examination was used to assess the gum base's color.
  2. Swelling Index: A 10 mL graduated cylinder was filled with 1 g of the gum base extract, which had been precisely weighed to calculate the swelling index. After recording the starting volume, distilled water was added. The cylinder was gently shaken and then allowed to sit at room temperature in the natural environment for a full day. Next, the final volume that the enlarged sediment occupied was measured.
  3. Solubility: The following solvents were used to evaluate the gum base's solubility:
    • Water: Ten milliliters of distilled water were combined with one gram of gum base.
    • Ethanol: 10 mL of ethanol was combined with 1 g of gum base.
    • Methanol: Ten milliliters of methanol were combined with one gram of gum base.
    • Dilute Hydrochloric Acid (Dil. HCl): 10 mL of diluted hydrochloric acid was combined with 1 g of gum base. 9

Figure 2: Flow chart for preparation of Caffeine-Medicated Chewing Gum

The process involved precisely weighing the gum base and then placing it in a china dish over a water bath at 60°C until it became soft. Once softened, caffeine powder (active ingredient) was incorporated, followed by coconut oil as a lubricant. The mixture was thoroughly blended to ensure uniform distribution. Subsequently, mannitol was added and mixed until a homogeneous composition was achieved. After achieving a uniform mixture, the temperature was reduced to below 40°C. Coloring and flavoring agents were gradually added while continuous mixing was maintained. The final gum mass was molded into the desired shape and set at room temperature before packaging, as in Figure 2.10

Table 1: Composition of Formulations for Caffeine-Infused Medicated Chewing Gum

Sr no

Ingredients

Uses

F1

F2

F3

1

Caffeine

API

50mg

50mg

50mg

2

Chicle gum base

Base

1000mg

1200mg

1400mg

3

Coconut oil

Lubricant

2-3drop

2-3drop

2-3drop

4

Mannitol

Sweetening agent

100mg

100mg

100mg

5

Elaichi

Flavoring agent

Q.S

Q.S

Q.S

6

Beetroot powder

Coloring agent

Q.S

Q.S

Q.S

7

Talc

Filler

Q.S

Q.S

Q.S

Evaluation Parameters of Caffeine-Infused Medicated Chewing Gum11-14

  1. Organoleptic properties: The physical characteristics of each batch of the chewing gum formulation, such as color, taste, and odor, were evaluated visually.
  2. Texture Analysis: Using the thumb and forefinger to compress the chewing gum, the texture was physically assessed. The tactile response was classified as solid bulk, nice mass, or sticky mass.
  3. Stickiness Test: The chewing gum formulation was put on a level surface and weighed 250 g for ten minutes. Following the allotted time, the gum's adhesion to the weight's surface was assessed.11-12
  4. Weight Variation: Twenty chewing gum pieces were chosen at random and weighed separately. To evaluate weight uniformity, the average weight was computed, and the percentage departure of each unit from the mean was ascertained 1, 13
  5. Hardness: A Monsanto hardness tester was used to gauge the medicated chewing gum's hardness. The findings were presented as standard deviation and mean hardness values.14
  6. Content Uniformity: For the investigation of content uniformity, three gum samples were chosen at random. A UV-visible spectrophotometer (UV-1800, Shimadzu) was used to measure absorbance at 272 nm after each sample was dissolved in 100 mL of phosphate buffer (pH 6.8) to determine the amount of caffeine present.12
  7. Drug Release Study: Mechanical motion is necessary for the release of medication from medicated chewing gum, in contrast to traditional dose forms. Using a basket and bead device, an in vitro dissolution study was carried out to simulate the chewing process. Every gum sample was submerged in 70 milliliters of phosphate buffer (pH 6.8) while attached to a magnetic bead in a basket. To replicate mastication, the device was set up on a magnetic stirrer running at 310–320 rpm. Sink conditions were maintained by taking out 0.5 mL aliquots of buffer at predefined intervals and replacing them right away with new buffer. To ascertain the caffeine content of the samples, UV-visible spectrophotometry was used. The release profile was assessed by plotting a cumulative drug release (%) vs. time graph.11
  8. Stability Studies: Stability studies were carried out in accordance with the International Conference on Harmonization's (ICH) guidelines. A short-term accelerated stability investigation was carried out for three months. Room temperature (25 ± 2°C), refrigerator temperature (4–8°C), and oven temperature (45°C ± 2°C) were the three temperatures at which the samples were stored. Each month, the sample was removed and analyzed for weight change, drug content uniformity (%), hardness (kg/cm2), physical appearance, and percentage CDR.

RESULTS:

Figure 3:   Standard Calibration Curve of Caffeine:

A standard calibration curve was created using the resultant data, which plotted absorbance against concentration. According to the obtained linear regression equation, y = 0.0478x + 0.008, where y stands for absorbance and x for concentration in µg/ml, the calibration curve showed a good linear connection. The calibration curve's high linearity and reliability for the quantitative detection of caffeine in the specified solvent system were indicated by the coefficient of determination (R2), which came out to be 0.999.

Table 2: Physicochemical Characterization of Isolated Gum Base

Sr No.

Parameters

Observation

1

Color

Yellow

2

Swelling index

No swelling

3

Solubility

In soluble in water

Soluble in dilute HCl, ethanol, and methanol

The fundamental physicochemical characteristics of the separated gum base were assessed. Table 2 illustrates how the gum looked yellow. When exposed to water, it did not swell, suggesting that hydrophilic expansion was absent. Furthermore, the gum base's solubility profile revealed that it dissolves in ethanol, methanol, and diluted hydrochloric acid (HCl) but not in water. These properties imply that the gum might find use in situations where solubility in organic solvents and water is preferred.

Table 3: Organoleptic and Physical Evaluation of Caffeine-Infused Medicated Chewing Gum

Sr no.

Parameter

Observation

F1

F2

F3

1

Color

Pink

Pink

Pink

2

Taste

Sweet

Sweet

Sweet

3

Odor

Pleasant

Pleasant

Pleasant

4

Stickiness

Non-Sticky

Non-Sticky

Non-Sticky

5

Hardness(kg/cm2)

3.5

3.7

4

6

Average weight SD ± mg

1000±0.05

1200±0.07

1400±0.04

Table 3 summarizes the physical characteristics and organoleptic characteristics of the medicated chewing gum formulations (F1, F2, and F3) that contained caffeine. Visual examination verified that all three formulations looked good, showing homogeneity in sensory qualities with a constant pink color, sweet taste, and nice odor. It was discovered that every formulation was non-sticky, which is ideal for patient compliance. The formulations' hardness values, which varied from 3.5 to 4.0 kg/cm2, showed sufficient mechanical strength for chewing. Furthermore, the formulations' average weights demonstrated adequate consistency with a low standard deviation, falling within the Indian Pharmacopoeia's (IP) suggested bounds. These findings imply that the manufactured.

Figure 4: Percentage Of Drug Content

The Drug content percentage indicates the proportion of the active pharmaceutical ingredient (API) present in each formulation, a critical parameter in evaluating the consistency and effectiveness of the drug. Among the three formulations, Furthermore, the gum base's solubility profile revealed that it dissolves in ethanol, methanol, and diluted hydrochloric acid (HCl) but not in water.

Table 4: In Vitro Drug Release Profile of Medicated Chewing Gum Infused with Caffeine

Sr no.

Time

(Min)

Percentage Cumulative drug release

F1

F2

F3

1

0

15

8.3

2.9

2

2

37.6

32.06

25.45

3

4

45.3

40.10

32.40

4

6

62.04

56.12

49.96

5

8

83

77.31

70.42

6

10

88.5

83.3

74.25

7

12

94

87

75.85

Figure.5: Percentage Dug Release

F1 showed the highest and fastest drug release, reaching 94% at 12 minutes, according to the in vitro release data (Table 4, Figure 5). F3 had the least amount of release (75.85%), whereas F2 had the most (87%). With F1 at 15%, F2 at 8.3%, and F3 at 2.9%, the first release at 0 minutes also varied considerably, suggesting variations in formulation qualities. According to these findings, F1 is the best option for quick drug delivery.

Stability Studies

Table 5: Short-Term Stability Study of Caffeine-Infused Medicated Chewing Gum (F1)

Time

(week)

Evolution parameters

Physical appearance

Hardness

(kg/cm2)

Weight variation

Uniformity of drug content (%)

% CDR

0

Rose pink

3.5

0.05%

48.02

94

1

Rose pink

3.5

0.05%

48.02

94

2

Rose pink

3.5

0.05%

48.02

94

3

Rose pink

3.3

0.05%

47.58

93.6

4

Rose pink

3.1

0.05%

47.25

93.1

The formulation remains physically and chemically stable over four weeks, with minor reductions in hardness, drug content, and drug release. These changes suggest that the formulation retains its quality and performance within the stability period, with no significant degradation. Further long-term stability studies may be required to assess extended shelf-life performance.

DISCUSSION

Caffeine-infused medicated chewing gum was successfully formulated and evaluated using an isolated gum base, yielding promising outcomes. The spectrophotometric analysis demonstrated excellent linearity with a regression equation of y = 0.0478x + 0.008 and a coefficient of determination (R² = 0.999), confirming the method’s accuracy and reproducibility, consistent with the findings of Anbazhagan et al.15. The isolated gum base exhibited a yellow color, no swelling in water, and solubility in ethanol, methanol, and dilute hydrochloric acid, making it suitable for oral drug delivery systems where water resistance and organic solubility are critical. These observations align with the physicochemical characteristics reported by Jani et al. 16, while Goyal and Sharma17 highlighted the relevance of such natural polymers in achieving controlled drug release. Among the formulations, F1 demonstrated superior performance, with the highest drug content (48.02%) and rapid in vitro release (94% within 12 minutes), surpassing F2 and F3. This supports the earlier work of Singh et al., who reported optimized drug release from caffeine-based chewing gum18. Stability studies conducted over four weeks indicated only minimal changes in F1’s hardness and drug content, with no notable deterioration in physical appearance or performance, which is in agreement with the findings of Patel and Rajput on the short-term stability of similar formulations19. Additionally, Yadav and Pathak20 have highlighted the benefits of medicated chewing gums, such as their capacity to avoid hepatic first-pass metabolism, enhanced bioavailability, quick onset of action, and simplicity of administration. Jadhav and Shaikh 21 further emphasized the adaptability of caffeine-infused chewing gum for pediatric use, without compromising efficacy or patient compliance.

CONCLUSION

The successful manufacture and testing of caffeine-infused medicated chewing gum, using an isolated gum base, demonstrates its potential as an effective oral drug delivery technique. F1 stood out as a good candidate for additional development among the developed formulations due to its ideal performance in terms of drug content, fast in vitro release, and short-term stability. The formulation's stability and effectiveness, along with the physicochemical characteristics of the separated gum basis, suggest its suitability for quick-acting, convenient caffeine delivery. However, more in vivo pharmacokinetic research and long-term stability evaluations are necessary to guarantee its therapeutic applicability.

REFERENCES

  1. Gururajbhat KM, Vadlamudi HC, Patil MC. Formulation and Evaluation of Medicated Chewing Gum for Buccal Drug Delivery. Res J Pharm Technol. 2021;14(10):5300-5306.
  2. Mishra S, Chatterjee A, Sharma V. Development and Evaluation of Terbutaline Sulphate Medicated Chewing Gum for Pediatric Asthma Patients. Res J Pharm Technol. 2024;17(1):101-106.
  3. Singh R, Rath G, Goyal AK. Natural Polymers in Pharmaceutical Applications: An Overview. Res J Pharm Technol. 2022;15(4):1705-1711.
  4. Sharma P, Tiwari S, Kumar A. Enhancement of Solubility and Dissolution of Poorly Soluble Drugs Using Solid Dispersion: A Recent Approach. Res J Pharm Technol. 2025;18(2):498-503.
  5. Pujari A, Wani S, Deshmukh M. Formulation and Evaluation of Vitamin C Medicated Chewing Gum Using Natural Prolamin Gum Base. Res J Pharm Technol. 2025;18(3):765-770.
  6. Pravalika M, Archana J. Simultaneous Estimation of Sodium Benzoate and Caffeine in Soft Drinks by UV Spectroscopy. Res J Pharm Technol. 2023;16(5):2436-2440.
  7. Maximiano FA, da Silva MA, Daghastanli KR, de Araujo PS, Chaimovich H, Cuccovia IM. A convenient method for lecithin purification from fresh eggs. Quim Nova. 2008;31(4):910–913.
  8. Patil S, Patil P, Patil R. Comparative Study on Natural Gum Bases Used in Chewing Gum Formulations. J Emerg Technol Innov Res. 2024;11(5):183–190.
  9. Aslani A, Jalilian F. Design, formulation and evaluation of caffeine chewing gum. Adv Biomed Res. 2013;2:72.
  10. Gururajbhat A, Kulyadi GP, Tippavajhala VK. A Comprehensive Review on Formulation, Preparation, Evaluation and Applications of Medicated Chewing Gum. Res J Pharm Technol. 2021;14(3):1760–1766.
  11. Muthukumar S, Nijanthan S, Vinesha R, Sundarajan R, Sridevi M, Salabha A. Formulation and Evaluation of Medicated Chewing Gum Consisting of Dextromethorphan and Guaifenesin for the Treatment of Cough. Res J Pharm Technol. 2021;14(5):2445-2449.
  12. Paradkar M, Gajra B, Patel B. Formulation development and evaluation of medicated chewing gum of anti-emetic drug. Saudi Pharm J. 2016;24(2):153-164.
  13. Bagdane A. Formulation Developement & Evaluation of Atenolol Based Medicated Chewing Gum. iMedPub J. 2021;1–8.
  14. Yadav HK, Mahesh KP, Uniyal S, Ayaz A. Formulation and evaluation of medicated chewing gum as antiplaque and antibacterial agent. J Young Pharm. 2014;6(4):3.
  15. Anbazhagan S, Kumar D, Kaur R. Spectrophotometric estimation of caffeine in pharmaceutical preparations. Int J Pharm Sci Res. 2023;14(2):789–793.
  16. Jani GK, Shah DP, Prajapati VD, Jain VC. Gums and mucilages: versatile excipients for pharmaceutical formulations. Asian J Pharm Sci. 2022;17(3):215–228. Goyal RK, Sharma P. Natural polymers and their applications in drug delivery. Int J Pharm Tech Res. 2021;14(1):56–62.
  17. Indian Pharmacopoeia Commission. Indian Pharmacopoeia 2020. Ghaziabad: IPC; 2020.
  18. Patel H, Rajput SJ. Stability studies of medicated chewing gum of metoclopramide. Res J Pharm Technol. 2021;14(8):4291–4296
  19. Yadav S, Pathak K. Medicinal chewing gums: a modern era of dosage form. J Pharm Bioall Sci. 2023;15(2):119–126
  20. Jadhav KR, Shaikh IS. Formulation and evaluation of palatable chewing gum containing caffeine for pediatric patients. Res J Pharm Technol. 2023;16(5):2200–2205.

Reference

  1. Gururajbhat KM, Vadlamudi HC, Patil MC. Formulation and Evaluation of Medicated Chewing Gum for Buccal Drug Delivery. Res J Pharm Technol. 2021;14(10):5300-5306.
  2. Mishra S, Chatterjee A, Sharma V. Development and Evaluation of Terbutaline Sulphate Medicated Chewing Gum for Pediatric Asthma Patients. Res J Pharm Technol. 2024;17(1):101-106.
  3. Singh R, Rath G, Goyal AK. Natural Polymers in Pharmaceutical Applications: An Overview. Res J Pharm Technol. 2022;15(4):1705-1711.
  4. Sharma P, Tiwari S, Kumar A. Enhancement of Solubility and Dissolution of Poorly Soluble Drugs Using Solid Dispersion: A Recent Approach. Res J Pharm Technol. 2025;18(2):498-503.
  5. Pujari A, Wani S, Deshmukh M. Formulation and Evaluation of Vitamin C Medicated Chewing Gum Using Natural Prolamin Gum Base. Res J Pharm Technol. 2025;18(3):765-770.
  6. Pravalika M, Archana J. Simultaneous Estimation of Sodium Benzoate and Caffeine in Soft Drinks by UV Spectroscopy. Res J Pharm Technol. 2023;16(5):2436-2440.
  7. Maximiano FA, da Silva MA, Daghastanli KR, de Araujo PS, Chaimovich H, Cuccovia IM. A convenient method for lecithin purification from fresh eggs. Quim Nova. 2008;31(4):910–913.
  8. Patil S, Patil P, Patil R. Comparative Study on Natural Gum Bases Used in Chewing Gum Formulations. J Emerg Technol Innov Res. 2024;11(5):183–190.
  9. Aslani A, Jalilian F. Design, formulation and evaluation of caffeine chewing gum. Adv Biomed Res. 2013;2:72.
  10. Gururajbhat A, Kulyadi GP, Tippavajhala VK. A Comprehensive Review on Formulation, Preparation, Evaluation and Applications of Medicated Chewing Gum. Res J Pharm Technol. 2021;14(3):1760–1766.
  11. Muthukumar S, Nijanthan S, Vinesha R, Sundarajan R, Sridevi M, Salabha A. Formulation and Evaluation of Medicated Chewing Gum Consisting of Dextromethorphan and Guaifenesin for the Treatment of Cough. Res J Pharm Technol. 2021;14(5):2445-2449.
  12. Paradkar M, Gajra B, Patel B. Formulation development and evaluation of medicated chewing gum of anti-emetic drug. Saudi Pharm J. 2016;24(2):153-164.
  13. Bagdane A. Formulation Developement & Evaluation of Atenolol Based Medicated Chewing Gum. iMedPub J. 2021;1–8.
  14. Yadav HK, Mahesh KP, Uniyal S, Ayaz A. Formulation and evaluation of medicated chewing gum as antiplaque and antibacterial agent. J Young Pharm. 2014;6(4):3.
  15. Anbazhagan S, Kumar D, Kaur R. Spectrophotometric estimation of caffeine in pharmaceutical preparations. Int J Pharm Sci Res. 2023;14(2):789–793.
  16. Jani GK, Shah DP, Prajapati VD, Jain VC. Gums and mucilages: versatile excipients for pharmaceutical formulations. Asian J Pharm Sci. 2022;17(3):215–228. Goyal RK, Sharma P. Natural polymers and their applications in drug delivery. Int J Pharm Tech Res. 2021;14(1):56–62.
  17. Indian Pharmacopoeia Commission. Indian Pharmacopoeia 2020. Ghaziabad: IPC; 2020.
  18. Patel H, Rajput SJ. Stability studies of medicated chewing gum of metoclopramide. Res J Pharm Technol. 2021;14(8):4291–4296
  19. Yadav S, Pathak K. Medicinal chewing gums: a modern era of dosage form. J Pharm Bioall Sci. 2023;15(2):119–126
  20. Jadhav KR, Shaikh IS. Formulation and evaluation of palatable chewing gum containing caffeine for pediatric patients. Res J Pharm Technol. 2023;16(5):2200–2205.

Photo
Reshma Sawant
Corresponding author

Rani Chennamma College of Pharmacy, Belagavi.

Photo
Lakshmi Kurbet
Co-author

Rani Chennamma College of Pharmacy, Belagavi.

Photo
Vijayanand Pujari
Co-author

Rani Chennamma College of Pharmacy, Belagavi.

Photo
Shruthi Kuligod
Co-author

Rani Chennamma College of Pharmacy, Belagavi.

Photo
Vidya Dalawal
Co-author

Rani Chennamma College of Pharmacy, Belagavi.

Photo
Sachin Pujari
Co-author

Rani Chennamma College of Pharmacy, Belagavi.

Photo
Priyanka Khavare
Co-author

Rani Chennamma College of Pharmacy, Belagavi.

Vijayanand Pujari, Reshma Sawant*, Lakshmi Kurbet, Shruthi Kuligod, Vidya Dalawal, Sachin Pujari, Priyanka Khavare, A Novel Approach to Caffeine Delivery: Formulation and Evaluation of Chicle-Based Medicated Chewing Gum, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 6, 5765-5774. https://doi.org/10.5281/zenodo.15771138

More related articles
Quality Assurance in Pharmaceutical Manufacturing ...
Sachin Chalge, Vinod Chaware, Tejas Sharma, Dr. Shivshankar D. M...
Anthelmintic Potential of Carica Papaya Seed Extra...
Sayed Nazira , Qureshi Mohammad Kaif, Ayesha Choudhary, Sayed Rah...
Cardiac Transplantation in Pediatrics: Drugs and T...
Edwin Dias, Hasna Fathima K. P., ...
A Review On Medicinal Importance Of Tridax Procumbens Linn ...
Monali S. Ghuge, Nikita K. Andhale, Sonali S. Ghuge, ...
An Overview on Preparation Methods and Evaluation of Transdermal Patches ...
D. Rama Brahma Reddy , D. Tejaswi, K. Hima Sankar, K. Venkatesh, G. Trinath Babu, V. Suresh, B. Upen...
Related Articles
HIF-PHI for Management of Anaemia of Chronic Kidney Disease: An Overview ...
Sona Toji, Anu Benedict, Ashna Saju, Maria George, Lincy George, ...
Emulgel: New Potential for Enhanced Topical Medication Delivery...
Mona Piplani, Kriti Sharma, Saloni Bhatti, Pankaj Bhateja, Ankush Goyal, Neeru Malik, ...
Quality Assurance in Pharmaceutical Manufacturing : Ensuring Consistency and Saf...
Sachin Chalge, Vinod Chaware, Tejas Sharma, Dr. Shivshankar D. Mhaske, Sanket Kakade, ...
More related articles
Quality Assurance in Pharmaceutical Manufacturing : Ensuring Consistency and Saf...
Sachin Chalge, Vinod Chaware, Tejas Sharma, Dr. Shivshankar D. Mhaske, Sanket Kakade, ...
Anthelmintic Potential of Carica Papaya Seed Extracts in Paediatric Candies: A N...
Sayed Nazira , Qureshi Mohammad Kaif, Ayesha Choudhary, Sayed Rahebar, Raashi Sayed , Foorkan Fakki,...
Quality Assurance in Pharmaceutical Manufacturing : Ensuring Consistency and Saf...
Sachin Chalge, Vinod Chaware, Tejas Sharma, Dr. Shivshankar D. Mhaske, Sanket Kakade, ...
Anthelmintic Potential of Carica Papaya Seed Extracts in Paediatric Candies: A N...
Sayed Nazira , Qureshi Mohammad Kaif, Ayesha Choudhary, Sayed Rahebar, Raashi Sayed , Foorkan Fakki,...